Primaquine for preventing relapses in people with Plasmodium vivax malaria.

Abstract

The objectives are (1) to compare primaquine plus chloroquine with chloroquine alone for preventing relapses in people with P. vivax malaria; and (2) to compare primaquine of any dosage or duration with the standard primaquine regimen of 15 mg/day for 14 days for preventing relapses in people with P. vivax malaria.

Citation

Galappaththy, G.N.L.; Omari, A.A.A. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Cochrane Database of Systematic Reviews (2003) Issue 3, Art. No.: CD004389. [DOI: 10.1002/14651858.CD004389]

Primaquine for preventing relapses in people with Plasmodium vivax malaria.

Help us improve GOV.UK

Don’t include personal or financial information like your National Insurance number or credit card details.